Total Payments
$10,677
2024 Payments
$922.71
Companies
45
Transactions
339
Medicare Patients
5,380
Medicare Billing
$694,198
Payment Breakdown by Category
Food & Beverage$6,576 (61.6%)
Travel$3,788 (35.5%)
Consulting$150.00 (1.4%)
Other$98.74 (0.9%)
Education$63.91 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,576 | 326 | 61.6% |
| Travel and Lodging | $3,788 | 10 | 35.5% |
| Consulting Fee | $150.00 | 1 | 1.4% |
| Entertainment | $98.74 | 1 | 0.9% |
| Education | $63.91 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,688 | 39 | $0 (2024) |
| Flowonix Medical Incorporated | $970.91 | 3 | $0 (2020) |
| Relievant Medsystems, Inc. | $885.12 | 9 | $0 (2023) |
| Abbott Laboratories | $661.68 | 26 | $0 (2020) |
| Medtronic USA, Inc. | $525.04 | 19 | $0 (2020) |
| Nevro Corp. | $394.75 | 15 | $0 (2020) |
| Jazz Pharmaceuticals Inc. | $265.68 | 10 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $228.75 | 16 | $0 (2024) |
| Pernix Therapeutics Holdings, Inc. | $224.28 | 13 | $0 (2018) |
| Egalet US Inc | $222.74 | 20 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $922.71 | 10 | Boston Scientific Corporation ($795.66) |
| 2023 | $1,004 | 12 | Relievant Medsystems, Inc. ($885.12) |
| 2022 | $132.03 | 4 | Boston Scientific Corporation ($109.51) |
| 2021 | $455.31 | 21 | BOSTON SCIENTIFIC CORPORATION ($131.69) |
| 2020 | $684.89 | 36 | Abbott Laboratories ($329.44) |
| 2019 | $1,228 | 56 | Nevro Corp. ($247.87) |
| 2018 | $2,219 | 82 | Flowonix Medical Incorporated ($859.24) |
| 2017 | $4,031 | 118 | BOSTON SCIENTIFIC CORPORATION ($2,307) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $47.83 | General |
| Category: Drug Infusion Systems | ||||||
| 09/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $52.09 | General |
| Category: General - Therapies_NMD | ||||||
| 09/13/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $417.95 | General |
| Category: General - Therapies_NMD | ||||||
| 09/13/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $240.87 | General |
| Category: General - Therapies_NMD | ||||||
| 09/13/2024 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $59.22 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Gastroenterology | ||||||
| 07/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Opioid Analgesic | ||||||
| 06/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.18 | General |
| Category: Opioid Analgesic | ||||||
| 04/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/09/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $23.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $5.75 | General |
| Category: Pain | ||||||
| 07/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $70.37 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/28/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $181.26 | General |
| Category: Pain | ||||||
| 06/28/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $150.31 | General |
| Category: Pain | ||||||
| 06/27/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $27.49 | General |
| Category: Pain | ||||||
| 06/27/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: Pain | ||||||
| 06/26/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $46.30 | General |
| Category: Pain | ||||||
| 06/23/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| Category: Pain | ||||||
| 06/23/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Pain | ||||||
| 05/04/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/02/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Travel and Lodging | Cash or cash equivalent | $403.80 | General |
| Category: Pain | ||||||
| 09/22/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/30/2022 | Boston Scientific Corporation | Spectra WaveWriter (Device) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Spectra WaveWriter_NMD | ||||||
| 05/26/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $37.90 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 933 | 9,938 | $407,954 | $92,048 |
| 2022 | 17 | 1,258 | 12,723 | $624,698 | $146,619 |
| 2021 | 14 | 747 | 2,365 | $408,916 | $122,953 |
| 2020 | 35 | 2,442 | 4,954 | $1.2M | $332,578 |
Total Patients
5,380
Total Services
29,980
Medicare Billing
$694,198
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 408 | $56,090 | $21,232 | 37.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 33 | 33 | $55,800 | $13,459 | 24.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 46 | 64 | $40,640 | $9,556 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 121 | $21,404 | $7,919 | 37.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 32 | 32 | $22,500 | $7,914 | 35.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 22 | 38 | $67,551 | $6,261 | 9.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 28 | 43 | $45,675 | $5,409 | 11.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 25 | 33 | $20,955 | $5,233 | 25.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 22 | 38 | $27,600 | $3,481 | 12.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 159 | 280 | $7,000 | $3,123 | 44.6% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 97 | 7,700 | $7,700 | $2,519 | 32.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $3,960 | $1,517 | 38.3% |
| 00520 | Anesthesia for other closed procedure on chest | Facility | 2023 | 15 | 15 | $11,785 | $1,492 | 12.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 66 | 230 | $10,120 | $1,146 | 11.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 15 | $3,942 | $759.40 | 19.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 89 | 857 | $3,428 | $671.59 | 19.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 11 | 11 | $1,804 | $356.14 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 177 | 388 | $69,080 | $32,604 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 282 | $35,046 | $17,701 | 50.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 50 | 85 | $161,535 | $15,709 | 9.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 54 | 68 | $43,180 | $12,775 | 29.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 23 | 29 | $39,600 | $11,867 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $23,650 | $9,980 | 42.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 48 | 83 | $64,000 | $8,255 | 12.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2022 | 29 | 39 | $24,765 | $7,710 | 31.1% |
About Dr. Charles Roberts, MD
Dr. Charles Roberts, MD is a Anesthesiology healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366456162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Roberts, MD has received a total of $10,677 in payments from pharmaceutical and medical device companies, with $922.71 received in 2024. These payments were reported across 339 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,576).
As a Medicare-enrolled provider, Roberts has provided services to 5,380 Medicare beneficiaries, totaling 29,980 services with total Medicare billing of $694,198. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Addiction Medicine, Hospice and Palliative Medicine
- Location Crestview Hills, KY
- Active Since 07/28/2006
- Last Updated 06/08/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1366456162
Products in Payments
- PRECISION (Device) $1,799
- Prometra II (Device) $970.91
- Intracept (Device) $885.12
- GENERAL - PAIN MANAGEMENT (Device) $454.59
- Senza Spinal Cord Stimulation System (Device) $394.75
- Proclaim Family of SCS IPGs (Device) $368.47
- KYPHON Balloon Kyphoplasty (Device) $368.22
- Prialt (Drug) $265.68
- SPECTRA WAVEWRITER (Device) $244.25
- ZOHYDRO ER (Drug) $224.28
- RELISTOR ORAL (Drug) $193.30
- AIMOVIG (Biological) $168.99
- Neuromodulation Dspsbls and Accs (Device) $166.68
- Nucynta (Drug) $164.07
- Dysport 300 U-1 (Drug) $147.57
- Aimovig (Biological) $139.38
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $128.96
- SCS IPGs (Device) $126.53
- XTAMPZA (Drug) $117.97
- GENERAL PAIN MANAGEMENT (Device) $116.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.